These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4757549)

  • 1. Treatment of carcinoma of the bladder by infusion of the anticancer agent (mitomycin C) via the internal iliac artery.
    Ogata J; Migita N; Nakamura T
    J Urol; 1973 Dec; 110(6):667-70. PubMed ID: 4757549
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH; Bouffioux C; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH; Harzmann R; Erdmann D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.
    Huland H; Otto U; Droese M; Klöppel G
    J Urol; 1984 Jul; 132(1):27-9. PubMed ID: 6427483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels during intravesical instillation of mitomycin-C.
    Kurth KH; de Wall JG; van Oosterom AT; de Jong EA; Tjaden UR
    Prog Clin Biol Res; 1985; 185B():81-93. PubMed ID: 3929272
    [No Abstract]   [Full Text] [Related]  

  • 6. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM; van der Meijden AP; Franssen MP
    Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative intra-arterial infusion chemotherapy for patients with bladder cancer.
    Kubota Y; Kakizaki H; Numasawa K; Suzuki K; Kato H
    Eur Urol; 1989; 16(3):189-94. PubMed ID: 2501099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on chemotherapy of urinary bladder cancer. V. Experimental studies of the blood level of anticancer agent under continuous injection into the internal iliac artery and infusion into the lumen of the urinary bladder in dogs].
    Ogata J; Nakamura T; Migita N
    Nihon Hinyokika Gakkai Zasshi; 1971 Dec; 62(12):960-4. PubMed ID: 5169064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prophylaxis of recurrence of superficial bladder tumor by diluted postoperative continuous intravesical instillation of anti-tumor solutions].
    Uchida T; Kobayashi K; Honda N; Arakawa T; Omata T; Endo T; Ishibashi A; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1985 Mar; 76(3):354-9. PubMed ID: 2411987
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the chemotherapy of cancer of urinary bladder. I. Clinical studies on treatment with continuous infusion of anticancer agent into the internal iliac artery.
    Nakamura T
    Nihon Hinyokika Gakkai Zasshi; 1969 Jul; 60(7):633-56. PubMed ID: 5388370
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trials with localized mitomycin instillation therapy for superficial urothelial bladder carcinoma].
    Flüchter SH; Bichler KH; Harzmann R; Erdmann D
    Onkologie; 1982 Feb; 5(1):42-5. PubMed ID: 6803202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
    Drago PC; Badalament RA; Lucas J; Drago JR
    J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C in the treatment of metastatic transitional cell carcinoma of urinary bladder.
    Early K; Elias EG; Mittelman A; Albert D; Murphy GP
    Cancer; 1973 May; 31(5):1150-3. PubMed ID: 4705151
    [No Abstract]   [Full Text] [Related]  

  • 15. An experimental study of the chemotherapy of carcinoma of the urinary bladder.
    Ogata J; Migita N; Nakamura T
    Invest Urol; 1974 Jan; 11(4):265-70. PubMed ID: 4809515
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the chemotherapy of urinary bladder cancer. 3. Studies on the effect of the continuous infusion of anticancer agent into the internal iliac artery on DNA content in cellular nucleus both of human bladder cancer and canine bladder epithelium].
    Migita N
    Nihon Hinyokika Gakkai Zasshi; 1970 Jul; 61(7):658-72. PubMed ID: 5465594
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of mitomycin C perfusion after bladder tumor surgery].
    Zhou CL
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood and tissue levels of mitomycin C after intravesical instillation].
    Flüchter SH; Hlobil H; Harzmann R; Rothe KF; Bichler KH
    Urol Int; 1983; 38(6):321-8. PubMed ID: 6419427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytology as a possible marker to identify patients who require prophylaxis.
    Huland H; Schneider A; Huland E; Arndt R
    Prog Clin Biol Res; 1990; 350():35-9. PubMed ID: 2117288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.